RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes

A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes

Add to Collection
RCTs A Doustmohammadian, A Nezhadisalami… - Frontiers in …, 2022 - frontiersin.org

Chapter : Section1
Journal Year : 2022
Cited by : 4.0

… and classified according to the World Health Organization (WHO) … All individuals’ laboratory data were gathered at baseline … on liver enzyme and Fibroscan in Indian patients with non-…..... Read More

Keywords : ["randomize tripleblind control clinical trial evaluation", "nonalcoholic fatty liver disease without diabete", "treatment", "sitagliptin", "patient"]
PubMed Link : https://www.frontiersin.org/articles/10.3389/fmed.2022.937554/full
Google Scholar Link : https://scholar.google.com/scholar?cites=14820034845395313495&as_sdt=5,39&sciodt=0,39&hl=en&num=20